A Hormone-Dependent Module Regulating Energy Balance  by Wang, Biao et al.
A Hormone-Dependent Module
Regulating Energy Balance
Biao Wang,1,2 Noel Moya,1 Sherry Niessen,4 Heather Hoover,4 Maria M. Mihaylova,3 Reuben J. Shaw,3 John R. Yates III,4
Wolfgang H. Fischer,1 John B. Thomas,2,* and Marc Montminy1,*
1Peptide Biology Laboratories
2Molecular Neurobiology Laboratory
3Molecular and Cellular Biology Laboratory
The Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, La Jolla, CA 92037, USA
4The Center for Physiological Proteomics, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA
*Correspondence: jthomas@salk.edu (J.B.T.), montminy@salk.edu (M.M.)
DOI 10.1016/j.cell.2011.04.013SUMMARY mammalian orthologs, and over 75% of known human diseaseUnder fasting conditions, metazoans maintain
energy balance by shifting from glucose to fat
burning. In the fasted state, SIRT1 promotes cata-
bolic gene expression by deacetylating the forkhead
factor FOXO in response to stress and nutrient depri-
vation. The mechanisms by which hormonal signals
regulate FOXO deacetylation remain unclear, how-
ever. We identified a hormone-dependent module,
consisting of the Ser/Thr kinase SIK3 and the class
IIa deacetylase HDAC4, which regulates FOXO
activity in Drosophila. During feeding, HDAC4 is
phosphorylated and sequestered in the cytoplasm
by SIK3, whose activity is upregulated in response
to insulin. SIK3 is inactivated during fasting, leading
to the dephosphorylation and nuclear translocation
of HDAC4 and to FOXO deacetylation. SIK3 mutant
flies are starvation sensitive, reflecting FOXO-depen-
dent increases in lipolysis that deplete triglyceride
stores; reducing HDAC4 expression restored lipid
accumulation. Our results reveal a hormone-regu-
lated pathway that functions in parallel with the
nutrient-sensing SIRT1 pathway to maintain energy
balance.INTRODUCTION
Obesity is a major risk factor in the development of insulin resis-
tance, which is characterized by an inability for insulin to promote
glucose uptake into muscle and to inhibit glucose production by
the liver. Obesity-dependent increases in circulating free fatty
acids have been associated with ectopic deposition of lipid in
liver and muscle, where they interfere with insulin signaling
(Kim et al., 2004).
Because of its short life cycle and ease of genetic manipula-
tion, Drosophila has emerged as an important model organism
for the study of obesity and diabetes (Baker and Thummel,
2007). A considerable percentage of all fly genes have clear596 Cell 145, 596–606, May 13, 2011 ª2011 Elsevier Inc.genes have functional orthologs in flies (Reiter and Bier, 2002).
Indeed virtually all of the known components of the insulin
signaling pathway are also present in the fly.
Glucose and lipid homeostasis in Drosophila is maintained by
a group of neurosecretory cells in the brain that produce insulin-
like peptides (Ikeya et al., 2002). Fasting metabolism is coordi-
nated by a distinct group of cells in the ring gland that elaborate
adipokinetic hormone (AKH) (Kim and Rulifson, 2004). Both
hormones maintain energy balance through their actions on
the fat body, the fly counterpart of mammalian liver and adipose
tissue. Disruption of insulin-producing cells in Drosophila leads
to increases in circulating glucose levels, mimicking certain
features of type II diabetes.
Insulin has been shown to regulate glucose and lipid metabo-
lism by triggering a cascade of lipid kinases that culminate in the
activation of the Ser/Thr kinase AKT (Brazil and Hemmings,
2001). In turn, AKT regulates the expression of metabolic
programs in part through the phosphorylation and cytoplasmic
sequestration of the forkhead transcription factor FOXO (Barthel
et al., 2005).
Superimposed on effects of AKT, FOXO activity is also in-
hibited through acetylation by the histone acetyl transferase
paralogs P300 and CBP (Fukuoka et al., 2003; Matsuzaki et al.,
2005). Acetylation has been shown to disrupt FOXO activity by
reducing its DNA-binding affinity, leading to increases in AKT-
mediated phosphorylation (Matsuzaki et al., 2005). Conversely,
FOXO is activated in part through deacetylation by the NAD+-
dependent deacetylase SIRT1 (Brunet et al., 2004; Daitoku
et al., 2004; Frescas et al., 2005) in response to nutrient depriva-
tion, although the regulatory effects of feeding and fasting
hormones on SIRT1 or other deacetylases have not been
addressed.
Here we show that Drosophila SIK3, a member of the AMPK
family of Ser/Thr kinases, plays a critical role in energy balance.
We found that SIK3 is activated by AKT during feeding, and
that upon activation it promotes lipid storage by blocking
FOXO activity. We have further shown that SIK3 regulates
FOXO activity by modulating its deacetylation by a class IIa
HDAC. Taken together, these studies show that SIK3 links
insulin signaling to FOXO-dependent changes in triglyceride
storage.
Figure 1. Reduced Fat Stores in SIK3
Mutant Flies, See Also Figure S1
(A) Diagram of SIK3 (CG15072) genomic locus is
depicted. Location of P element EY06260 shown,
along with SIK348 and SIK372 deletions generated
by imprecise excision. SIK3+51 is a precise exci-
sion control line. SIK348 lacks the first (noncoding)
exon, resulting in a significant reduction of SIK3
mRNA. The SIK372 deletion extends through the
first two exons, removing sequences that encode
part of the SIK3 kinase domain, and acts as a null
allele.
(B) qPCR analysis of SIK3 mRNA levels in SIK3+
(SIK3+51) and SIK3 (SIK348) adult male and female
flies under feeding conditions.
(C) Immunohistochemical analysis of SIK3
expression in fat bodies of WT (yw) and SIK3
(yw;SIK348/Df(2R)P34) L3 larvae. SIK3 protein
shown in green, DNA shown in red. Scale bar,
10 mm.
(D and E) Relative fasting (24 hr) or ad libitum
feeding lipid levels (D) and starvation sensitivities
(E) of SIK3+ (SIK3+51) and SIK3 (SIK348) flies. (n =
10 per genotype for lipid measurement and n = 50
for starvation assays).
(F) Effect of fat body (FB) specific expression of
SIK3 on lipid levels in SIK3 flies. FB> (FB-GAL4/+),
SIK3,FB > (FB-GAL4,SIK348/ SIK348), SIK3,
FB > SIK3 (FB-GAL4, SIK348 / SIK348;UAS-SIK3/+),
SIK3,UAS-SIK3(SIK348,UAS-SIK3/+), and FB >
SIK3 (FB-GAL4 /+; UAS-SIK3/+) flies are shown.
n = 16 per genotype.
(G) Fat body-specific expression of SIK3 rescues
starvation sensitivity in SIK3 flies. Shown are
survival curves for SIK3, FB > SIK3 (FB-GAL4,
SIK348/SIK348;UAS-SIK3/+), SIK3, UAS-SIK3
(SIK348, UAS-SIK3/+), and SIK3, FB > (FB-
GAL4, SIK348/ SIK348) flies. (n = 97–127 per
genotype).
(H) Lipid levels in SIK3 mutant flies with fat body-
specific expression of wild-type or catalytically
inactive (K70M) SIK3, SIK2, and AMPK. Genotypes
are as follows: SIK3, FB > (FB-GAL4, SIK348/
SIK348), SIK3+, FB > (FB-GAL4 /+), SIK3, FB >
SIK3.WT (FB-GAL4, SIK348/SIK348;UAS-SIK3/+),
SIK3+, FB > SIK3.WT (FB-GAL4 /+;UAS-SIK3/+),
SIK3, FB > SIK3.K70M (FB-GAL4, SIK348/
SIK348;UAS-SIK3.K70M/+), SIK3+, FB>SIK3.K70M
(FB-GAL4/+;UAS-SIK3.K70M/+), SIK3, FB > SIK2
(FB-GAL4, SIK348/SIK348;UAS-SIK2/+), SIK3+, FB > SIK2 (FB-GAL4/+;UAS-SIK2/+), SIK3, FB > AMPK (FB-GAL4, SIK348/SIK348;UAS-AMPKTD/+), and SIK3+,
FB > AMPK (FB-GAL4 /+;UAS-AMPKTD/+). n = 12 per genotype. Data are averages ± SEM (**p < 0.01; *p < 0.05).RESULTS
SIK3 Promotes Lipid Storage
Within the AMPK family of Ser/Thr kinases, the Salt-inducible
kinases (SIKs) have been shown to regulate hepatic glucose
metabolism in mammals following their phosphorylation and
activation by LKB1, a master kinase for the AMPK family (Dentin
et al., 2007; Koo et al., 2005). The SIKs are highly conserved
through evolution; there are two SIKs encoded by theDrosophila
genome: CG4290 (fly SIK2) and CG15072 (fly SIK3) (Okamoto
et al., 2004). We have investigated the physiological roles ofSIK3 by mutating this gene using P element-mediated imprecise
excision (see Experimental Procedures).
We generated a series of deletions affecting the SIK3 gene
(Figure 1A). Because SIK3 null mutants (SIK372) die during early
larval stages, we used a viable SIK3 hypomorphic allele (SIK348)
(Figures 1A–1C and Figures S1A–S1C available online). SIK348
homozygous mutants showed markedly decreased lipid stores,
and they were more sensitive to starvation than control (SIK3+51)
flies (Figures 1D and 1E). By contrast with its effects on fasting,
loss of SIK3 only modestly increased sensitivity (15%–17%) to
oxidative stress (Figures S1F and S1G). SIK348/SIK372 andCell 145, 596–606, May 13, 2011 ª2011 Elsevier Inc. 597
Figure 2. AKT Stimulates SIK3 Activity
during Feeding, See Also Figure S2
(A) Effect of fat-body specific AKT expression on
lipid levels in wild-type and SIK3 flies. Genotypes
are as follows: FB > (FB-GAL4/+), FB > AKT
(FB-GAL4/UAS-AKT), SIK3, FB > (FB-GAL4,
SIK348/ SIK348) and SIK3, FB > AKT (FB-GAL4,
SIK348/UAS-AKT, SIK348). n = 16 per genotype.
(B) SIK3 catalytic activity in 24 hr fasted versus
0.5 hr refed flies, as determined by relative
SIK3 autophosphorylation in fat bodies of flies
(ppl-GAL4/UAS-SIK3.WT) expressing HA-tagged
SIK3. Incorporation of g32P-labeled ATP by in vitro
kinase assay of anti-HA immunoprecipitates
shown. Immunoblot of total SIK3 protein amounts
also indicated.
(C) Immunoblot showing relative amounts of
phosphorylated SIK3 in fat bodies of wild-type and
chico mutant flies. Phospho-SIK3 levels deter-
mined using phospho-AKT substrate antibody
(PAS). Total SIK3 levels measured with SIK3
antisera on HA-immunoprecipitates prepared
from CON (ppl-GAL4,UAS-SIK3/+) and Chico
(chico1;ppl-GAL4,UAS-SIK3/+) flies under 24 hr
fasted or 0.5 hr refed conditions.
(D) In vitro kinase assays showing effect of recombinant AKT on phosphorylation of catalytically inactive (K70M) SIK3. Effect of mutating four putative AKT
phosphorylation sites (T281/486A.S293/401A; 4A) in SIK3 on 32P incorporation shown. Total protein amounts for wild-type and 4Amutant SIK3 proteins indicated
by Coomassie staining.
(E) Immunoblot showing effect of Ala substitutions at putative AKT phosphorylation sites in SIK3 (4A) on SIK3 phosphorylation inDrosophila S2 cells. Immunoblot
with PAS antiserum was performed on HA-immunoprecipitates prepared from transfected cells. Exposure to insulin (0.5 hr) indicated. Total amounts of SIK3
shown. Relative amounts of phospho-SIK3, determined by densitometric analysis, indicated below each lane.
(F) Lipid levels in SIK3mutant flies following fat body-specific expression of wild-type or AKT phosphorylation-defective (4A) SIK3. Genotypes are as follows: FB >
(FB-GAL4/+), SIK3, FB > (FB-GAL4, SIK348/ SIK348), SIK3, FB > SIK3.WT (FB-GAL4, SIK348/SIK348;UAS-SIK3/+), and SIK3, FB > SIK3.4A (FB-GAL4, SIK348/
SIK348;UAS-SIK3.4A/+). n = 16 per genotype. Data are averages ± SEM (**p < 0.01; *p < 0.05).SIK348/Df(2R)P34 transheterozygotes showed a similar lipid
phenotype to SIK348 homozygotes, suggesting that SIK348 is
a strong hypomorphic allele (Figures S1D and S1E). Further sup-
porting this idea, SIK3 mRNA and protein levels are dramatically
reduced in SIK348 flies (Figures 1B and 1C).
SIK3 shows high levels of expression in the fat body, the fly
equivalent of the mammalian liver and adipose tissue. Targeted
transgenic expression of wild-type SIK3 in fat body restored lipid
stores and starvation resistance and an associated develop-
mental delay in SIK3 mutants (Figures 1F and 1G and data not
shown). Transgenic expression of SIK3 in fat body also rescued
the lethality of SIK372 null mutant flies (Figure S1C). By contrast,
a kinase-dead form of SIK3 (SIK3.K70M) had no rescuing effect
in this setting, indicating that SIK3 catalytic activity is required to
maintain lipid balance in vivo (Figure 1H). Indeed, LKB1 phos-
phorylation-defective SIK3 (SIK3.T196A) also failed to rescue
the metabolic phenotype in fat body (data not shown).
Because they share similar substrate specificities, other
AMPK family members might be predicted to substitute for
SIK3 in fat body. Supporting this idea, expression of SIK2 in fat
body fully rescued lipid accumulation (Figure 1H); but AMPK
did not, indicating that SIKs have distinct regulatory properties
from other members of this family.
Insulin Regulates SIK3 Activity
Having found that SIK3 mutant flies are sensitive to starvation,
we considered that SIK3 activity may be required for insulin598 Cell 145, 596–606, May 13, 2011 ª2011 Elsevier Inc.effects on lipid accumulation during feeding. Supporting
a genetic link between SIK3 and the insulin signaling pathway,
fat body-specific overexpression of the insulin-responsive Ser/
Thr kinase AKT increased lipid levels in control flies (Verdu
et al., 1999), but it had no effect in SIK3 mutants (Figure 2A).
Because SIK3 appears to be required for lipid accumulation,
we tested whether insulin regulates SIK3 activity. Supporting
this notion, SIK3 catalytic activity in fat body was elevated during
refeeding and decreased in response to fasting, as measured by
in vitro kinase assay of HA-tagged SIK3 immunoprecipitates
prepared from HA-SIK3 transgenic flies (Figure 2B). Moreover,
exposure of Drosophila S2 cells to insulin increased the phos-
phorylation of SIK3 at potential AKT phosphorylation sites, as
evaluated using a phospho-AKT substrate antibody (PAS); these
effects were diminished when cells were depleted of AKT with
a double-stranded AKT oligonucleotide (Figure S2A). Consistent
with the proposed role of insulin signaling on SIK3 activity,
disruption of chico, the fly homolog of insulin receptor substrate
(Bo¨hni et al., 1999), also blocked SIK3 phosphorylation (Fig-
ure 2C). Although it had no effect on fat stores by itself, disruption
of one chico allele reduced lipid levels in SIK3 hypomorphic
mutant flies, demonstrating a genetic interaction between these
effectors (Figure S2B).
To identify residues in SIK3 that undergo phosphorylation
during feeding, we performed mass spectrometry studies on
HA-SIK3 immunoprecipitates from transgenic flies expressing
HA-tagged SIK3 in the fat body. This analysis revealed a number
Figure 3. SIK3 Blocks brummer Lipase-Dependent Lipolysis, See
Also Figure S3
(A) Relative effect of AKH receptor (AKHR) and brummer (bmm) deficiency on
lipid levels in wild-type and SIK3 mutant flies. Genotypes are as follows:
SIK3+,w (w), SIK3,w (SIK348), SIK3+,AKHR (AKHR1), SIK3,AKHR
(AKHR1, SIK348), SIK3+,bmm (bmm1), SIK3,bmm (SIK348;bmm1). n = 16
per genotype.
(B) qPCR analysis of bmm mRNA amounts in wild-type and SIK3 mutant flies
under feeding conditions. Effect of expressingwild-typeor kinase-dead (K70M)
SIK3 in fat body on bmmmRNA amounts indicated. Genotypes are as follows:
SIK3+ (FB-GAL4/+), SIK3: (FB-GAL4, SIK348/SIK348), SIK3+, FB > SIK3.WT
(FB-GAL4 /+;UAS-SIK3/+), SIK3, FB > SIK3.WT (FB-GAL4, SIK348/SIK348;
UAS-SIK3/+), SIK3+, FB > SIK3.K70M (FB-GAL4/+;UAS-SIK3.K70M/+),
SIK3, FB > SIK3.K70M (FB-GAL4, SIK348/SIK348;UAS-SIK3.K70M/+) flies.
Data are averages ± SEM (**p < 0.01).
(C–E) Time course analysis of lipid depletion (C, n = 14–20 per genotype),
catabolic gene expression (D), and FOXO as well as AKT and SIK3 dephos-
phorylation (E) during fasting in adult wild-type flies. For (E), AKT phosphory-
lated FOXO migrates slower than the unphosphorylated protein (see
Figure S4D). Densitometric analysis of phospho-SIK3 amounts from two
independent experiments shown.
(F) qPCR analysis of mRNA amounts for bmm and other fasting-inducible
genes (PEPCK, lip3, and 4E-BP) in wild-type (w) and FOXO (FOXO21/FOXO25)
mutant flies under fasting (24 hr) or ad libitum feeding conditions.of phosphorylation sites, including the LKB1 site at Thr196,
and two residues (Ser401, Thr 486) that, along with Thr281
and Ser293, correspond to consensus (RXRXXS/T) or near-
consensus AKT phosphorylation sites in SIK3 and in its mamma-
lian homolog Sik2 (Figures S2D and S2E). In keeping with these
results, recombinant active AKT appeared to phosphorylate
each of the four residues in SIK3 in vitro, by mutational analysis
of a kinase-dead (K70M) form of SIK3 (Figure S2C). Furthermore,
mutant SIK3.4A containing alanine substitutions at all four sites
was not phosphorylated by AKT in vitro or in cells exposed to
insulin (Figures 2D and 2E). We next compared the rescuing
activities of wild-type and phosphorylation-defective SIK3 in
fat body. Although expression of wild-type SIK3 rescued lipid
accumulation in SIK3 mutant flies, AKT phosphorylation-defec-
tive SIK3.4A did not (Figure 2F), indicating that insulin promotes
lipid accumulation during feeding in part through the AKT-medi-
ated phosphorylation of SIK3. Although these studies support
the notion that AKT is the physiological upstream kinase of
SIK3 in fly fat body, we cannot exclude the involvement of other
AGC kinases that may regulate SIK3 in a similar fashion.
SIK3 Inhibits Expression of Brummer Lipase
In principle, the loss of SIK3 expression could reduce lipid accu-
mulation by blocking lipogenesis or by increasing lipolysis.
Arguing against an effect on lipid absorption or on adipogenesis,
high-fat feeding with soy oil rescued the fat storage defects and
accompanying developmental delay in SIK3mutants (Figure S3A
and data not shown). Moreover, lipogenic gene expression
(SREBP, ACC, and FAS) in SIK3 mutants was comparable to
wild-type, suggesting that triglyceride synthesis is not altered
in SIK3 mutants (Figure S3B).
Under fasting conditions, increases in circulating AKH stimu-
late the mobilization of triglycerides by triggering the AKH
receptor (AKHR) and stimulating cAMP signaling in fat body
(Gro¨nke et al., 2007). In parallel, decreases in insulin signaling
lead to upregulation of brummer (bmm) lipase, the fly homolog
of adipose triglyceride lipase (ATGL) in mammals (Gro¨nke
et al., 2005). To evaluate the regulatory contributions of each
pathway, we crossed SIK3 mutant flies to AKHR or bmm
mutants.
Deletion of AKHR only partially rescued lipid accumulation in
SIK3 mutant flies (Figure 3A), arguing against a direct effect of
SIK3 on the AKH pathway per se. By contrast, SIK3/bmm double
mutant flies were as obese as bmm single mutants, indicating
that Bmm likely acts downstream of SIK3. Supporting this
notion, levels of bmm mRNA were upregulated in SIK3 mutant
flies compared to wild-type (Figure 3B); elevated bmm mRNA
levels were reduced following fat body-specific expression of
wild-type but not kinase-dead (K70M) SIK3. Collectively, these
results indicate that SIK3 promotes lipid accumulation during
feeding by downregulating the bmm gene.
SIK3 Modulates FOXO Activity
Under fasting conditions, decreases in insulin signaling have
been found to stimulate catabolic gene expression through the
dephosphorylation and nuclear entry of the forkhead activator
FOXO (Ju¨nger et al., 2003). Based on the presence of consensus
FOXO-binding sites at 56 and 46 in the bmm promoterCell 145, 596–606, May 13, 2011 ª2011 Elsevier Inc. 599
Figure 4. SIK3 Inhibits FOXO Activity, See Also
Figure S4
(A and B) Immunohistochemical analysis and quantification of
FOXO localization in SIK3+ (SIK3+51/ Df(2R)P34) and SIK3
(SIK348/Df(2R)P34) L3 larvae. Arrows point to nuclear-local-
ized FOXO protein. Scale bar; 10 mm. (B) Percentage of cells
with nuclear FOXO staining in (A) shown graphically. At least
400 cells were counted for each genotype.
(C and D) Effect of SIK3 depletion (C) or fat body-specific
overexpression (D) on FOXO phosphorylation in flies. Geno-
types are as follows: w (w), SIK3 (SIK348), FOXO (FOXO21/
FOXO25), Con (r4-GAL4,UAS-HAFOXO/+), and SIK3 over-
expression (O/E) (r4-GAL4,UAS-HA-FOXO/UAS-SIK3). In (C),
flies were fasted for 24 hr (0) and then refed for 0.5, 1, or 5 hr.
In (D), flies were fasted for 24 hr and refed for 0.5 hr.
(E and F) Effect of FOXO gene disruption on brummer
mRNA amounts (E) and lipid levels (F) in SIK3 mutant flies.
Genotypes are as follows: SIK3+,w (w), SIK3,w (SIK348),
SIK3+,FOXO (FOXO21/FOXO25), and SIK3,FOXO (SIK348;
FOXO21/FOXO25).
n = 24 per genotype. Data are averages ± SEM (**p < 0.01).(Figure S3C), we considered that FOXOmay regulate bmm gene
expression.
We examined the kinetics of FOXO activation and lipid utiliza-
tion in fasted flies (Figures 3C–3E). Amounts of phosphorylated
AKT fell over a 48 hr period after food withdrawal, leading to cor-
responding decreases in amounts of phosphorylated SIK3.
Amounts of dephosphorylated, active FOXO increased in parallel
with SIK3 inactivation in response to starvation; these were
accompanied by increases in bmm mRNA levels and in lipid
disposal. Consistent with a regulatory role for FOXO, fasting-
associated increases in bmm gene expression were blocked in
FOXO mutant flies (Figure 3F). Conversely, FOXO overexpres-
sion enhanced bmm promoter activity in reporter assays; these
effects were blocked by mutation of the 46 FOXO-binding
site on the bmm promoter or by overexpression of SIK3 (Figures
S3C and S3D). FOXO overexpression in fat body was also suffi-
cient to enhance bmm gene expression and to promote lipid
depletion (Figures S3E and S3F).
Having seen that bmm gene expression is elevated in SIK3
mutant flies, we wondered whether SIK3 negatively regulates
FOXO activity. Supporting this idea, amounts of nuclear-local-
ized active FOXO were increased 5-fold in ad libitum fed SIK3
mutant larvae compared to controls (Figures 4A and 4B). As600 Cell 145, 596–606, May 13, 2011 ª2011 Elsevier Inc.a result, mRNA amounts for other FOXO target
genes (4E-BP, PEPCK) were upregulated in SIK3
mutants relative to control flies (Figures S4A
and S4B).
In the fed state, increases in insulin signaling
reduce catabolic gene expression through AKT-
mediated phosphorylation and cytoplasmic trans-
location of FOXO (Teleman et al., 2008). In prin-
ciple, the increase in FOXO activity in SIK3 mutant
flies could reflect decreases in either insulin
expression or insulin signaling. Arguing these
possibilities, mRNA amounts for insulin-like
peptide 2 (Ilp2) were similar in wild-type and SIK3mutant flies (Figure S4C); and refeeding upregulated AKT phos-
phorylation comparably in both groups (Figure 4C).
By contrast with its effects in wild-type flies, refeeding
increased FOXO phosphorylation only modestly in SIK3 mutants
(Figure 4C and Figure S4D). Conversely, refeeding stimulated
FOXO phosphorylation more robustly in transgenic flies overex-
pressing SIK3 in fat body relative to controls (Figure 4D). Pointing
to a genetic link between SIK3 and FOXO, disruption of the
FOXO gene restored both bmm expression and lipid accumula-
tion in SIK3 mutant flies (Figures 4E and 4F). Taken together,
these results suggest that SIK3 inhibits lipolysis during feeding
by reducing FOXO activity and thereby lowering bmm gene
expression in fat body.
SIK3 Regulates a Class IIa HDAC
We considered that SIK3 could modulate FOXO activity directly
through phosphorylation. Although purified SIK3 was capable of
phosphorylating recombinant FOXO in vitro, it did so with low
stoichiometry and at nonconsensus sites (Ser66, Ser531),
which, when mutated to alanine, did not appear to enhance
FOXO activity (Figures S4E–S4G). These results suggest that
SIK3 likely regulates FOXO activity through an intermediary
factor.
Figure 5. SIK3 Phosphorylates HDAC4 and Promotes
Its Cytoplasmic Translocation, See Also Figure S5
(A) Alignment of SIK consensus phosphorylation motif with
conserved phospho-acceptor sites in HDAC4 and in
mammalian class IIa HDACs (Hdac4/5/7).
(B) Autoradiogram showing relative phosphorylation of
wild-type (HDAC4.WT) and phosphorylation-defective
(HDAC4.3A) HDAC4 polypeptides by SIK3 in in vitro kinase
assays using 32P-labeled ATP. Lower panel shows total
protein amounts for HDAC4.WT and HDAC4.3A by
Coomassie staining.
(C) Immunoblot showing effect of wild-type and PKA phos-
phorylation-defective SIK3 (S563A) on amounts of phospho
(Ser239) and total HDAC4 in transfected HepG2 cells. Effect
of cAMP agonists (0.5 mM IBMX, 0.5 mM 8-Br-cAMP; 4 hr) on
phospho (Ser239) HDAC4 amounts shown. Bottom, diagram
of SIK3 showing location of inhibitory PKA phosphorylation
site relative to catalytic and ubiquitin-binding (UBA) domains
indicated. Below, alignment of PKA phosphorylation sites in
Drosophila SIK3 and mouse SIK2.
(D) Immunohistochemical analysis of FLAG-HDAC4 localiza-
tion in fed control (r4-GAL4/+) and ad libitum fed or 10 hr
fasted HDAC4-overexpressing (r4-GAL4/UAS-HDAC4) L3
larvae. HDAC4 protein shown in green, DNA shown in red.
Scale bar, 10 mm.To identify this putative regulator, we performed a genetic
screen using a set of 270 chromosomal deletions covering
95% of the Drosophila genome. By capitalizing on an ectopic
wing vein phenotype caused by wing-specific knockdown of
SIK3 function as an easily scorable output for SIK3 activity, we
identified one deletion, Df(X)BSC713, which strongly sup-
pressed the loss of SIK3 function in wing (Figures S5A and
S5B). One of the genes deleted inDf(X)BSC713 is HDAC4, which
has previously been identified as a substrate for SIK phosphory-
lation in both C. elegans and mammals (Berdeaux et al., 2007;
van der Linden et al., 2006). Supporting a functional link in
Drosophila, removal of one copy of HDAC4 (HDAC4e04575) sup-
pressed effects of SIK3 loss of function (LOF) in the wing.
Conversely, gain of HDAC4 function (GOF) by overexpression
in wing enhanced SIK3 LOF, and it suppressed SIK3 gain of
function (GOF) (Figure S5C). Taken together, these results
suggest that HDAC4 acts downstream of SIK3 in Drosophila.
Phosphorylation has been shown to sequester class IIa
HDACs in the cytoplasm by stimulating their interaction with
14-3-3 proteins (Bassel-Duby and Olson, 2006). Following their
dephosphorylation, class IIa HDACs migrate to the nucleus
where they modulate cellular gene expression by associating
with relevant transcription factors. Consistent with the presence
of three conserved consensus SIK phosphorylation sites known
to be phosphorylated by SIKs in C. elegans and mammals (Ber-
deaux et al., 2007; van der Linden et al., 2006), wild-type fly
HDAC4 was efficiently phosphorylated in vitro and in HepG2
andDrosophila S2 cells by SIK3 (Figures 5A–5C and Figure S5E).
In contrast, SIK3 did not phosphorylate a mutant HDAC4 poly-
peptide containing alanine substitutions at all three putativeCell 1Ser phosphor-acceptor sites (Figures 5B and 5C).
Indeed, phosphorylation-defective HDAC4 was
more active than wild-type in promoting theectopic wing vein phenotype (Figure S5D). In keeping with the
ability of the cAMP-dependent kinase PKA to disrupt the activity
of the SIKs through phosphorylation at a conserved Ser residue
corresponding to Ser563 in SIK3 (Screaton et al., 2004), expo-
sure to cAMP agonist reduced amounts of phosphorylated
HDAC4 in cells expressing wild-type SIK3 (Figure 5C and Fig-
ure S5F). By contrast, exposure to cAMP agonist actually
increased HDAC4 phosphorylation in cells expressing PKA
phosphorylation-defective S563A mutant SIK3.
Realizing that HDAC4 phosphorylation promotes its nucleocy-
toplasmic shuttling, we tested whether HDAC4 subcellular locali-
zation is regulated by dietary status. Under feeding conditions,
HDAC4 was largely confined to the cytoplasm of larval fat body
cells; fasting triggered nuclear shuttling of HDAC4 (Figure 5D).
To determine whether SIK3 is sufficient to promote HDAC4 shut-
tling, we employed HeLa cells, which are defective in the AMPK
family master kinase LKB1 (Hawley et al., 2003). Consistent with
the absence of endogenous SIK-related activities, HDAC4 was
primarily nuclear localized inHeLacells.Overexpressionofconsti-
tutively active SIK3T196E increased the cytoplasmic localization
of HDAC4 (Figure S5G). Taken together, these results indicate
that HDAC4 activity in fat body is regulated by phosphorylation
or dephosphorylation in response to feeding and fasting signals.
HDAC4 Activates FOXO
Given our finding that SIK3 promotes the translocation of HDAC4
to the cytoplasm, we wondered whether nuclear HDAC4 modu-
lates FOXO activity. Supporting this possibility, HDAC4 was
found to associate with FOXO in coimmunoprecipitation studies
of Drosophila S2 and HeLa cells expressing epitope-tagged45, 596–606, May 13, 2011 ª2011 Elsevier Inc. 601
Figure 6. HDAC4 Activates FOXO, See Also Figure S6
(A) Immunoblot of FOXO recovered from immunoprecipitates
of HDAC4 or control IgG prepared from Drosophila S2 cells.
Input amounts of transfected HDAC4 and FOXO shown.
(B) qPCR analysis of mRNA amounts for fasting inducible
genes (PEPCK, bmm, CPTI) in HDAC4 hypomorphic mutant
flies (top) or in flies expressing phosphorylation-defective,
constitutively active HDAC4.3A in fat body (bottom). Geno-
types are as follows: FB > (FB-GAL4/+) and FB > HDAC4.3A
(FB-GAL4/+;UAS-HDAC4.3A/+) for overexpression assays.
For HDAC4 hypomorphic mutant flies, genotypes are
HDAC4+ (HDAC4KG09091/+) and HDAC4 (HDAC4KG09091/
HDAC4e04575). Effects of HDAC4 (top) examined in 24 hr
fasted flies. Effects of HDAC4.3A examined under ad libitum
feeding conditions.
(C) Immunoblot showing time course of FOXO phosphoryla-
tion and acetylation during refeeding in wild-type (w), SIK3
mutant (SIK348). Ac-FOXO protein detected using anti-ac-
FOXO1 (K242/245) antibody after immunoprecipitation with
anti-acetyl-lysine antibody. Extract from FOXO mutant
(FOXO21/FOXO25) flies included to show specificity of ac-
FOXO1 and nondiscriminating FOXO antisera.
(D) Top: Schematic showing domain organization of FOXO,
including DNA-binding domain (DBD), nuclear localization
sequence (NLS), nuclear export sequence (NES), and trans-
activation domain (TA). Middle: alignment of conserved lysine
residues in the DBDs ofDrosophila FOXO and human FOXO1.
Conserved lysine residues that undergo acetylation (Lys179,
182 in Drosophila; Lys 242, 245 in human) shown. Bottom:
Immunoblot showing Ac-FOXO and unphosphorylated
(FOXO) or phospho-FOXO (pFOXO) protein amounts in 24 hr
fasted or 1 hr refed wild-type (HDAC4+) and HDAC4 mutant
(HDAC4) flies. Relative amounts of acetylated FOXO,
determined by densitometric analysis, indicated above each
lane. Genotypes are as follows: HDAC4+ (HDAC4KG09091/+)
and HDAC4 (HDAC4KG09091/HDAC4e04575).
(E) In vitro deacetylation assay showing effect of purified
HDAC4 on deacetylation of a GST-FOXO (aa 95–195) poly-
peptide acetylated in vitro with the histone acetyl-transferase
P300. Immunoblot shows amounts of acetylated FOXO (Ac-FOXO) using anti-acetyl-lysine antibody. Input protein amounts for GST-FOXO (aa 95–195) and
HDAC4 proteins determined by Ponceau S staining.
(F) Effect of oral supplementation with class I/II HDAC inhibitor trichostatin A (TSA) in the food (10 mM) on fat body lipid levels in SIK3 mutant flies. n = 10 per
genotype. Genotypes are as follows: w (w) and SIK3 (SIK348).
Data are averages ± SEM (**p < 0.01; *p < 0.05).HDAC4 and FOXO (Figure 6A). Consistent with its proposed role
in regulating HDAC4 localization, overexpression of constitu-
tively active SIK3T.196E disrupted the FOXO:HDAC interaction
(Figure S6A). Furthermore, FOXO target gene expression was
downregulated in HDAC4 hypomorphic mutant flies (Figure 6B,
top). Conversely, mRNA amounts for PEPCK, bmm, and CPTI
were increased in transgenic flies overexpressing wild-type
HDAC4 in fat body (Figure S6B), whereas non-FOXO target
genes (e.g., HSL) were relatively unchanged.
To test whether HDAC4 regulates FOXO target gene expres-
sion in the fat body itself, we measured bmm mRNA levels in
fat bodies isolated from early L3 larvae expressing a constitu-
tively active HDAC4.3A transgene in fat body. bmm mRNA
amounts were elevated in fat bodies from transgenic compared
to control larvae, although the extent of bmm upregulation in
larval fat bodies wasmoremodest than in adult flies (Figure S6C).
Arguing against a general effect of this deacetylase on cellular
gene transcription, GAL4-driven expression of a GFP transgene
was unaffected byHDAC4 overexpression (Figure S6D). Pointing602 Cell 145, 596–606, May 13, 2011 ª2011 Elsevier Inc.to the importance of nuclear HDAC4, phosphorylation-defective
HDAC4 was more active than wild-type HDAC4 in stimulating
FOXO target gene expression in fat body (Figure 6B, bottom).
Consistent with the substantial upregulation of bmm in adult
flies, HDAC4.3A transgenic flies also had lower lipid stores,
and they were more sensitive to starvation compared to controls
(Figures S6E and S6F). Taken together, these results indicate
that HDAC4 is both necessary and sufficient to activate FOXO.
Under feeding conditions, P300 and CBP have been shown to
inhibit catabolic gene expression by acetylating FOXO1 at
conserved lysine residues within the forkhead domain (Daitoku
et al., 2004). Acetylation appears to reduce FOXO activity by
reducing its DNA-binding affinity and thereby enhancing its
phosphorylation by AKT (Frescas et al., 2005; Matsuzaki et al.,
2005). Conversely, stress and nutrient deprivation have been
found to increase FOXO activity during starvation through de-
acetylation by the NAD+-dependent deacetylase SirT1 and by
trichostatin A-sensitive class I/II histone deacetylases (Brunet
et al., 2004; Matsuzaki et al., 2005).
Figure 7. SIK3 Inhibits FOXO Activity via an HDAC4-Dependent Mechanism
(A–C) Effect of HDAC4 gene disruption on lipid levels (A), bmmmRNA amounts (B), and FOXO phosphorylation (C) in SIK3 mutant relative to control flies. Data in
panels A and B are from ad libitum fed flies. Data in panel C are from 1 hr refed flies. Genotypes are as follows: SIK3+(w), SIK3 (SIK348), SIK3+, HDAC4
(HDAC4KG09091/HDAC4e04575), and SIK3, HDAC4 (HDAC4KG09091/HDAC4e04575; SIK348), FOXO (FOXO21/FOXO25). n = 24 per genotype.
(D and E) Effect of fat body-specific depletion of HDAC4 (HDAC4i) on lipid levels (D) and bmm mRNA amounts (E) in SIK3 mutant relative to control flies under
feeding conditions. Genotypes are as follows: SIK3+,FB > (FB-GAL4/+), SIK3,FB > (FB-GAL4,SIK348/ SIK348), SIK3+,FB > HDAC4i(FB-GAL4/+;UAS-HDAC4
RNAi/+), and SIK3, FB > HDAC4i (FB-GAL4,SIK348/ SIK348; UAS-HDAC4 RNAi/+). n = 14–16 per genotype).
(F) Immunoblot showing amounts of phosphorylated mouse HDAC4 in extracts from primary hepatocytes following RNAi-mediated depletion of SIK2. Effect of
exposure to insulin (100 nM) for different times (in minutes) indicated.
(G) Immunoblot showing effect of glucagon (100 nM) on HDAC4 phosphorylation at Ser245 and on inhibitory phosphorylation of SIK2 at Ser587 in primary mouse
hepatocytes.
(H) qPCR analysis of PEPCK, Glucose 6 phosphatase, and NR4A2mRNA amounts in primary hepatocytes following exposure to glucagon (100 nM) for 1 hr. Effect
of adenovirus-encoded HDAC4/5 RNAs shown.In parallel with its stimulatory effects on FOXO phosphoryla-
tion, refeeding also enhanced FOXO acetylation in wild-type
flies, but not in SIK3 mutants (Figure 6C). By contrast, amounts
of acetylated FOXO were substantially increased in HDAC4
hypomorphic mutants after 24 hr of fasting, and they remained
elevated during refeeding (Figure 6D).
In principle, HDAC4 could reduce amounts of acetylated
FOXO by blocking its association with P300/CBP or by cata-
lyzing its deacetylation. Arguing for the latter scenario, purified
HDAC4 was capable of deacetylating FOXO, which had been
acetylated in vitro by the HAT coactivator P300 (Figures S6G
and S6E). Superimposed on its direct effects, HDAC4 may also
regulate FOXO activity through an association with HDAC
complexes. In mass spectrometry studies to identify HDAC4-
associated proteins in fat body, we recovered SMRTER, EBI,and HDAC3, all components of a deacetylase complex that
have been shown to interact with class IIa HDACs in mammalian
cells (Fischle et al., 2002) (Figure S6H). Consistent with the ability
of HDAC4 to promote FOXO deacetylation, either directly or
through its association with the SMRTER complex, addition of
the class I/II HDAC inhibitor trichostatin A (TSA) to the food
increased lipid levels in SIK3 mutant flies (Figure 6F).
SIK3 Inhibits HDAC4-Mediated Deacetylation of FOXO
Having observed that HDAC4 regulates FOXO activity, we tested
whether SIK3 modulates FOXO target gene expression via an
HDAC4-dependent mechanism. Disrupting HDAC4 expression,
either through P element-mediated insertion (Figures 7A–7C) or
through RNAi-mediated depletion in fat body (Figures 7D and
7E), restored lipid levels in SIK3 mutant flies. Consistent withCell 145, 596–606, May 13, 2011 ª2011 Elsevier Inc. 603
the increase in fat stores, bmm gene expression was also
reduced to wild-type levels in HDAC4/SIK3 double mutants. In
keeping with the proposed role of FOXO in this process,
amounts of phosphorylated, inactive FOXO were increased in
HDAC4/SIK3 doublemutants under refed conditions (Figure 7C).
Taken together, these results suggest that SIK3 inhibits lipolysis
during feeding by phosphorylating HDAC4 and blocking the de-
acetylation of FOXO.
Based on the proposed role of SIK3 and HDAC4 in fasting
metabolism, we tested whether this regulatory module is also
conserved in mammals. Exposure to insulin triggered the phos-
phorylation of mammalian HDAC4 at Ser245 in wild-type mouse
hepatocytes; these effects were disrupted following RNAi-medi-
ated depletion of SIK2, the mammalian homolog of fly SIK3,
which is expressed at highest levels in adipose and liver (Dentin
et al., 2007; Horike et al., 2003) (Figure 7F and Figure S7A).
Conversely, exposure of hepatocytes to glucagon promoted
the dephosphorylation of HDAC4 at Ser245, reflecting the inhib-
itory PKA-mediated phosphorylation of SIK2 at Ser587 (Fig-
ure 7G and Figure S7A).
Having seen effects of insulin and glucagon on phosphoryla-
tion of a mammalian class IIa HDAC, we tested whether fasting
or feeding signals also promote shuttling of these deacetylases.
Exposure of HepG2 hepatocytes to insulin promoted cyto-
plasmic translocation of a mammalian HDAC5-GFP fusion
protein (Figure S7B). Conversely, exposure to inhibitors of SIK
activity, such as PI3K inhibitor (LY294002) or FSK, stimulated
the nuclear translocation of HDAC5-GFP (Figure S7B).
We examined whether mammalian class IIa HDACs also regu-
late FOXO activity. Similar to Drosophila, endogenous mouse
HDAC4 was found by coimmunoprecipitation assay to associate
with endogenous Foxo1 in primary hepatocytes (Figure S7C). In-
hibiting class IIa HDACs, either by treatment with trichostatin A
or by RNAi-mediated depletion of HDAC4 andHDAC5, disrupted
the induction of gluconeogenic FOXO target genes (Pck1, G6p)
in response to glucagon (Figure 7H and Figures S7D and S7E).
Collectively, these studies demonstrate that the SIK/class IIa
HDAC module is conserved in mammals, where it promotes
catabolic gene expression through the upregulation of FOXO
activity (Figure S7F).
DISCUSSION
During fasting, metazoans maintain energy balance through
increases in triglyceride lipolysis by hormone-sensitive lipase
(HSL) and ATGL in response to hormonal signals. This process
is reversed during feeding, when increases in insulin signaling
promote fat storage in part through the inhibition of both lipases.
Although insulin has been shown to downregulate HSL activity
by upregulating phosphodiesterases that terminate cAMP
signaling (Kitamura et al., 1999), the mechanism by which it
inhibits ATGL expression is unknown.
We have shown that SIK3 is activated by AKT during feeding,
when it promotes lipid storage in adult flies by inhibiting FOXO
activity and thereby reducing the expression of brummer lipase,
the fly homolog of ATGL. Although insulin promotes fat storage in
mammals, loss of insulin signaling in chico null flies actually leads
to an increase in lipid stores. Loss of chico is thought to promote604 Cell 145, 596–606, May 13, 2011 ª2011 Elsevier Inc.broad changes in intracellular signaling in multiple tissues (Bo¨hni
et al., 1999; Clancy et al., 2001); these changes likely compen-
sate for loss of SIK3 activity in the fat body. Nevertheless, SIK3
activity is critical for lipid storage in a wild-type background.
SIK3 did not appear to inhibit FOXO activity directly through
phosphorylation but rather by blocking its deacetylation by
HDAC4. We found that class IIa HDACs are insulin- and cAMP-
regulated deacetylases that promote FOXO activation and
catabolic gene expression during fasting (Figure S7F); they are
inhibited through SIK-mediated phosphorylation and cyto-
plasmic translocation. In addition to SIK3, other Ser/Thr kinases
including calmodulin-dependent kinases and other members of
the AMPK family may also regulate class IIa HDAC shuttling
through phosphorylation at the same sites under different
conditions.
Fasting hormones disrupt SIK activity through PKA-mediated
phosphorylation, leading to the dephosphorylation and nuclear
translocation of class IIa HDACs. The subsequent upregulation
of FOXO activity by class IIa HDACs was unexpected because
these enzymes are thought to function in muscle and brain as
signal-dependent repressors of gene expression (Haberland
et al., 2009).
Acetylation has been proposed to modulate FOXO activity by
decreasing its DNA-binding affinity and thereby enhancing its
phosphorylation by AKT (Brent et al., 2008; Matsuzaki et al.,
2005). Consistent with this view, we found that the acetylation
and phosphorylation of FOXO increased contemporaneously
during refeeding; both FOXO modifications were decreased in
SIK3 mutant animals, reflecting the upregulation of HDAC4
activity. Indeed, disruption of HDAC4 restored FOXO phosphor-
ylation and target gene expression in SIK3 mutant flies. Although
fat body-specific rescue experiments demonstrate a SIK3
requirement in the fat body and argue for cell-autonomous
effects of HDAC4 on FOXO target gene expression, we cannot
rule out additional non-cell-autonomous effects of SIK3/
HDAC4 activity. For example, FOXO target gene induction in
response to fat body-specific HDAC4 overexpression, as de-
tected inwhole fly RNA, could additionally be occurring in tissues
other than the fat body.
Supporting a substantial role for these enzymes in glucose and
lipid metabolism, the effects of SIK3 and HDAC4 in Drosophila
appear to be conserved in mammals. We found that Sik2, the
mouse homolog of fly SIK3, mediates the phosphorylation and
inactivation of Hdac4 in mouse hepatocytes in response to
insulin. Conversely, exposure to glucagon increased Hdac4
activity through the PKA-mediated inhibition of Sik2. In an
accompanying paper, Mihaylova and colleagues (Mihaylova
et al., 2011) also show that mammalian class IIa HDACs are fast-
ing-regulated deacetylases, which increase FOXO target gene
expression in mice.
Consistent with our results in Drosophila, mutations in the
HDAC4 gene that result in haploinsufficiency have been associ-
atedwith obesity in humans, although the underlyingmechanism
remains unclear (Williams et al., 2010).
Taken together, these results suggest that the class IIa HDACs
and SIRT1 represent parallel pathways, which regulate fasting
programs following their activation by hormonal and nutrient
signals, respectively. In this regard, it is interesting to speculate
that mammalian class IIa HDACs may trigger catabolic gene
expression during early fasting, when circulating concentrations
of glucagon and catecholamines are typically high, whereas
SIRT1 may function primarily at later ‘‘protein-sparing’’ stages
of fasting, when cellular energy levels are low. Future studies
should provide additional insight into the roles of SIRT1 and
class IIa HDACs in the fasting adaptation.EXPERIMENTAL PROCEDURES
Fly Strains
P element insertion EY06260 (Bloomington #15962) was used to generate SIK3
deletions by imprecise excision. Two SIK3 deletion alleles were characterized:
SIK348 is a hypomorphic allele that removes the first exon, resulting in a signif-
icant reduction of SIK3 mRNA; SIK372 is a null allele that deletes the first two
exons, removing part of the kinase domain. Both SIK372 homozygotes and
SIK372/Df(2R)P34 are lethal in larval stages. The deletion endpoints for each
SIK3 mutant were determined by PCR and DNA sequencing. Flies were main-
tained on standard fly food at 25C with light-dark cycle (Percival Incubator,
Model: 136VL). Three- to five-day-old flies were used in each experiment.
For refeeding studies, flies were fasted for 24 hr and then shifted to standard
fly food for times indicated. For high-fat or trichostatin A feeding studies, 5%
soy oil (Sigma #S7381) or 10 mM trichostatin A (Sigma #T1952) was mixed
with the standard fly food.
Lipid Measurement
TAG measurement was performed as described (Palanker et al., 2009).
Samples were assayed by using a Modulus microplate spectrophotometer
at 560 nm. Lipid levels were normalized to protein amounts in each homoge-
nate by using a Bradford assay (Bio-Rad). Measurements were performed in
ad libitum fed adult flies unless otherwise indicated.
Starvation Assay
Three- to five-day-old flies were transferred to vials of 1% agar/PBS with filter
papers soaked with H2O, and dead flies were scored every 4–8 hr. For protein,
RNA, and lipid analysis, flies were fasted for about 24 hr unless otherwise
indicated.
Cell Culture and Transfection
Drosophila S2, HEK293T, and HepG2 cells were maintained as previously
described (Wang et al., 2008). HeLa cells were cultured in DMEM (Mediatech,
#10-017-CV) containing 10% FBS at 37C with 5% CO2. Transfections were
performed as reported (Wang et al., 2008). Human GFP-HDAC5 was em-
ployed for cell localization studies as described (Berdeaux et al., 2007).
Primary hepatocytes were cultured as described (Dentin et al., 2007). Ad-
Hdac4/5i viruses (Mihaylova et al., 2011) and Ad-Sik2i virus (Dentin et al.,
2007) were generated as reported. 10 p.f.u./cell of adenovirally encoded
Ad-Uni, Ad-Sik2i, Ad-Hdac4i, and Ad-Hdac5i were used for RNAi-mediated
knockdown experiments. After 2–3 days infection, cells were collected for
protein or RNA analysis.
Western Blot
Cells or flies were lysed on ice in lysis-buffer (50 mM Tris-HCl, 150 mM NaCl,
1 mM EDTA, 6 mM EGTA, 20 mM NaF, 1% Triton X-100, and protease inhib-
itors) for 15–20 min. After centrifugation at 13000 rpm for 15 min, supernatants
were reserved for protein determinations and SDS-PAGE analysis. The
following antibodies were used: anti-phospho-AKT substrate, anti-AKT, anti-
Foxo1, anti-pS239-HDAC4, anti-Ac-lysine, anti-ACC, and anti-phosphor-
PKA substrate antibodies are from Cell Signaling Technology; anti-Hsp90,
anti-HA, and anti-HDAC4 antibodies are from Santa Cruz Biotechnology;
anti-FLAG antibody is from Sigma; and anti-SIK2 antibody is from Abgent.
Drosophila FOXO antibodies are from O. Puig, and anti-Ac-FOXO1K242/245
antibody is from A. Fukamizu. Anti-SIK3 (Drosophila) rabbit polyclonal anti-
serum was prepared and affinity purified as described (Wagner et al., 2000)using recombinant GST-SIK3 (aa 381–695) as immunogen. Densitometric
analysis was carried out with Scion Image software.Statistical Analyses
Statistical significance was determined by using an unpaired two-tailed
Student’s t test with unequal variance. Data are presented as the average ±
standard error of the mean (SEM).SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
seven figures and can be found with this article online at doi:10.1016/j.cell.
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